Quest Diagnostics | DGX - Ebitda

Aktienkurs
196.27
Täglich Wechseln
-3.26 -1.63%
Monatlich
-0.10%
Jährlich
12.95%
Q2 Prognose
190.73




Ebitda Veränderung Datum
Acadia Healthcare USD 99.85M 73.17M 2025-12
Agilent USD 540M 74M 2025-09
Baxter International USD 426M 36M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Cardinal Health USD 981M 5M 2025-12
Centene USD -903M 1.02B 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Community Health Systems USD 395M 19M 2025-12
CVS Health USD 3.74B 349M 2025-12
Danaher USD 1.92B 204M 2026-03
DaVita Healthcare Partners USD 772.7M 89.45M 2025-12
Elevance Health USD 4.21B 2.02B 2026-03
Encompass Health USD 335.6M 35.5M 2025-12
HCA USD 3.8B 312M 2026-03
Henry Schein USD 291M 4M 2025-12
Humana USD -290M 1.11B 2025-12
Illumina USD 332M 12M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
McKesson USD 1.68B 418M 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Molina Healthcare USD 267M 385M 2026-03
Owens Minor USD 90.02M 2.15M 2025-12
Pediatrix Medical Group USD 65.84M 21.47M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Revvity USD 248.91M 48.52M 2025-12
Tenet Healthcare USD 1.18B 84M 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
UnitedHealth USD 9.99B 8.5B 2026-03
Universal Health Services USD 678.67M 8.07M 2025-12
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
Zoetis USD 1.04B 87M 2025-09